Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Textron
TXT
$14.1B
| $24.4M | 0.04% |
513,377
-727,996
| -59% | -$35.1M |
|
577
Sabesp
SBS
$16.3B
| $24.4M | 0.04% |
12,096,078
+3,095,213
| +34% | +$6.1M |
|
578
Hexcel
HXL
$7B
| $24.4M | 0.04% |
446,384
+413,948
| +1,276% | +$21.8M |
|
579
American International
AIG
$40.5B
| $24.2M | 0.04% |
387,294
-870,856
| -69% | -$55.9M |
|
580
Clorox
CLX
$13B
| $24.1M | 0.04% |
178,634
-596,284
| -77% | -$77.2M |
|
|
MJN
581
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $24.1M | 0.04% |
+270,000
| New | +$22.2M |
|
582
CBRE Group
CBRE
$44B
| $24M | 0.04% |
689,733
+681,840
| +8,639% | +$22.8M |
|
583
Pan American Silver
PAAS
$22.2B
| $23.9M | 0.04% |
1,366,226
+279,980
| +26% | +$5.09M |
|
|
PRMW
584
DELISTED
Primo Water Corporation
PRMW
| $23.9M | 0.04% |
1,934,751
+28,394
| +1% | +$320K |
|
585
BioCryst Pharmaceuticals
BCRX
$2.47B
| $23.8M | 0.04% |
2,838,649
+2,651,655
| +1,418% | +$18.4M |
|
586
MasTec
MTZ
$20.5B
| $23.8M | 0.04% |
595,361
+421,762
| +243% | +$16.1M |
|
587
Cal-Maine
CALM
$3.95B
| $23.7M | 0.04% |
644,999
+635,867
| +6,963% | +$25.4M |
|
588
Service Corp International
SCI
$11.5B
| $23.7M | 0.04% |
767,423
+291,509
| +61% | +$8.77M |
|
589
AGCO
AGCO
$7.71B
| $23.7M | 0.04% |
+393,430
| New | +$24.2M |
|
|
ONCE
590
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $23.6M | 0.04% |
442,993
-573,633
| -56% | -$34.1M |
|
|
TECD
591
DELISTED
Tech Data Corp
TECD
| $23.6M | 0.04% |
251,576
+196,132
| +354% | +$17.4M |
|
|
THS
592
DELISTED
Treehouse Foods
THS
| $23.6M | 0.04% |
278,443
+244,818
| +728% | +$19.6M |
|
593
Haemonetics
HAE
$4.93B
| $23.6M | 0.04% |
580,610
+149,739
| +35% | +$5.85M |
|
594
PUT
CVS Health
CVS
$120B
| $23.6M | 0.04% |
+300,000
| New | +$24M |
|
595
Petrobras Class A
PBR.A
$108B
| $23.5M | 0.04% |
2,543,974
-1,313,732
| -34% | -$12.5M |
|
596
Kratos Defense & Security Solutions
KTOS
$9.96B
| $23.4M | 0.04% |
3,006,138
+570,944
| +23% | +$4.55M |
|
|
HA
597
DELISTED
Hawaiian Holdings, Inc.
HA
| $23.3M | 0.04% |
501,856
+274,731
| +121% | +$14.1M |
|
598
Ingevity
NGVT
$2.37B
| $23.3M | 0.04% |
382,532
+111,236
| +41% | +$6.29M |
|
599
Armstrong World Industries
AWI
$7.53B
| $23.2M | 0.04% |
+503,905
| New | +$21.3M |
|
|
LGF.B
600
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $23.2M | 0.04% |
951,205
+375,130
| +65% | +$9.52M |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.